Cibus, Inc. (NASDAQ:CBUS) Short Interest Update

Cibus, Inc. (NASDAQ:CBUS) was the target of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 1,080,944 shares, an increase of 32.4% from the December 15th total of 816,246 shares. Currently, 3.9% of the company’s shares are sold short. Based on an average trading volume of 163,460 shares, the short-interest ratio is presently 6.6 days. Based on an average trading volume of 163,460 shares, the short-interest ratio is presently 6.6 days. Currently, 3.9% of the company’s shares are sold short.

Analyst Upgrades and Downgrades

CBUS has been the topic of a number of research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Cibus in a research report on Wednesday, October 8th. Canaccord Genuity Group restated a “buy” rating and issued a $15.00 price objective on shares of Cibus in a report on Monday, December 8th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $20.00.

Hedge Funds Weigh In On Cibus

A number of large investors have recently modified their holdings of the business. Bank of America Corp DE increased its position in shares of Cibus by 113.4% in the fourth quarter. Bank of America Corp DE now owns 35,536 shares of the company’s stock valued at $99,000 after acquiring an additional 18,885 shares during the last quarter. AQR Capital Management LLC bought a new position in Cibus in the first quarter valued at approximately $73,000. FNY Investment Advisers LLC acquired a new position in shares of Cibus during the 2nd quarter worth approximately $54,000. Warberg Asset Management LLC bought a new stake in shares of Cibus during the 2nd quarter worth approximately $41,000. Finally, Transce3nd LLC lifted its stake in Cibus by 29.1% in the second quarter. Transce3nd LLC now owns 52,656 shares of the company’s stock valued at $75,000 after acquiring an additional 11,861 shares during the last quarter. 33.81% of the stock is currently owned by institutional investors and hedge funds.

Cibus Stock Performance

Shares of NASDAQ CBUS opened at $1.90 on Monday. The firm has a 50 day moving average price of $1.61 and a 200 day moving average price of $1.52. The stock has a market cap of $103.13 million, a P/E ratio of -0.58 and a beta of 1.57. Cibus has a 52-week low of $1.09 and a 52-week high of $3.40.

Cibus (NASDAQ:CBUS) last released its quarterly earnings data on Thursday, November 13th. The company reported ($0.44) EPS for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.03). The firm had revenue of $0.62 million during the quarter, compared to the consensus estimate of $1.39 million. Cibus had a negative net margin of 3,133.92% and a negative return on equity of 133.90%. Analysts predict that Cibus will post -2.96 earnings per share for the current fiscal year.

Cibus Company Profile

Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company’s platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.

The company’s core business centers on trait development services and licensing partnerships.